ZFP57 and pancreatic neoplasm: It was demonstrated that miR-193a-5p targets ZFP57, suppressing its expression and upregulating cyclin 1, CDK4, and Bcl-2 to activate the Wnt/β-catenin pathway, enhancing radioresistance in pancreatic cancer cell tumors (35).